![]() |
|
|
Vol. 63, Issue 1, 73-80, January 2003
Department of Molecular Biosciences, Discipline of Biochemistry,
the University of Adelaide, Adelaide, Australia (S.C.D., B.K.M.); and
Chromatin and Transcriptional Regulation Group, the John Curtin School
of Medical Research, Australian National University, Canberra,
Australia (D.T.)
We have previously identified an upstream 556-bp enhancer domain for
the chicken CYP2H1 gene that responds to phenobarbital and binds several transcription factors, including the orphan chicken
xenobiotic receptor (CXR). By contrast, the promoter lacks a CXR site
and is not inducible by phenobarbital. Although it has been established
that CXR can interact with the coactivator SRC-1, there are no reports
as to whether other coactivators may be important for
phenobarbital-mediated inducibility. Our studies using the adenovirus
E1A wild-type protein, which inhibits the coactivators cAMP response
element binding protein (CBP) and CBP associated factor (p/CAF),
provide evidence for the involvement of one or both of these
coactivators at the enhancer but not at the promoter of the
CYP2H1 gene. The observations that mutant E1A proteins
did not affect the enhancer activity and that inhibition by wild-type
E1A was reversed by CBP and p/CAF confirmed the involvement of these
coactivators in the induction process. We propose that the intrinsic
histone acetyl transferase activity of one or both of these
coactivators participates in chromatin remodeling thereby stimulating
drug induction of the promoter. This proposal was supported by
experiments with the histone deacetylase inhibitor, trichostatin A,
which resulted in the superinduction of the drug response but had
little effect on basal expression of the CYP2H1 gene.
The work provides evidence for the first time for the involvement of
the coactivators CBP and p/CAF in the phenobarbital-mediated induction
of the CYP2H1 gene.
This article has been cited by other articles:
![]() |
K. Swales and M. Negishi CAR, Driving into the Future Mol. Endocrinol., July 1, 2004; 18(7): 1589 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||